These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1947002)
21. [Evaluation of thermal damage after hyperthermia on murine experimental tumor by 31P-NMR spectroscopy--correlation between ATP and growth curve]. Kitada N; Akagi K; Uda M; Hasegawa T; Oshima T; Tanaka Y Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):669-73. PubMed ID: 1508639 [TBL] [Abstract][Full Text] [Related]
22. [Study of anti-tumor effects of hyperthermia combined with hydralazine on experimental tumor]. Aoki Y; Akagi K; Kitada N; Tanaka Y; Fritz-Zieroth B Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Nov; 55(14):987-92. PubMed ID: 8570396 [TBL] [Abstract][Full Text] [Related]
23. 31P nuclear magnetic resonance spectroscopy studies of tumor energy metabolism and its relationship to intracapillary oxyhemoglobin saturation status and tumor hypoxia. Rofstad EK; DeMuth P; Fenton BM; Sutherland RM Cancer Res; 1988 Oct; 48(19):5440-6. PubMed ID: 3416301 [TBL] [Abstract][Full Text] [Related]
24. Histopathological changes in transplanted mouse mammary carcinoma following hyperthermia with or without radiation. Jo S; Hiraoka M; Akuta K; Nishimura Y; Furuta M; Takahashi M; Abe M Jpn J Cancer Res; 1986 Nov; 77(11):1095-101. PubMed ID: 3098719 [TBL] [Abstract][Full Text] [Related]
25. Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Evelhoch JL; Bissery MC; Chabot GG; Simpson NE; McCoy CL; Heilbrun LK; Corbett TH Cancer Res; 1988 Sep; 48(17):4749-55. PubMed ID: 3409216 [TBL] [Abstract][Full Text] [Related]
26. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma. Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434 [TBL] [Abstract][Full Text] [Related]
27. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor. Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851 [TBL] [Abstract][Full Text] [Related]
28. Changes in 31P nuclear magnetic resonance with tumor growth in radioresistant and radiosensitive tumors. Koutcher JA; Alfieri AA; Barnett DC; Cowburn DC; Kornblith AB; Kim JH Radiat Res; 1990 Mar; 121(3):312-9. PubMed ID: 2315448 [TBL] [Abstract][Full Text] [Related]
29. Response of mammary tumors of C3H/He mice to hyperthermia and bleomycin in vivo. Ma F; Hiraoka M; Jo S; Akuta K; Nishimura Y; Takahashi M; Abe M Radiat Med; 1985; 3(4):230-3. PubMed ID: 2425397 [TBL] [Abstract][Full Text] [Related]
30. Metabolic alterations in implanted human tumors after combined radiation and hyperthermia therapy measured by in vivo 31P MRS. Kimura H; Itoh S; Kawamura Y; Nakatsugawa S; Ishii Y Magn Reson Imaging; 1994; 12(1):109-19. PubMed ID: 8295498 [TBL] [Abstract][Full Text] [Related]
31. 31P NMR spectroscopy can predict the optimum interval between fractionated irradiation doses. Murata O; Sakurai H; Mitsuhashi N; Hasegawa M; Yamakawa M; Kurosaki H; Hayakawa K; Niibe H Anticancer Res; 1998; 18(6A):4297-301. PubMed ID: 9891481 [TBL] [Abstract][Full Text] [Related]
32. Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas. Evelhoch JL; Keller NA; Corbett TH Cancer Res; 1987 Jul; 47(13):3396-401. PubMed ID: 3581077 [TBL] [Abstract][Full Text] [Related]
33. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy. Mahmood U; Alfieri AA; Thaler H; Cowburn D; Koutcher JA Cancer Res; 1994 Sep; 54(18):4885-91. PubMed ID: 8069854 [TBL] [Abstract][Full Text] [Related]
34. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo. Overgaard J; Radacic MM; Grau C Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787 [TBL] [Abstract][Full Text] [Related]
35. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971 [TBL] [Abstract][Full Text] [Related]
36. [Impact of localized microwave hyperthermia on the pH-distribution in malignant tumors (author's transl)]. Vaupel P Strahlentherapie; 1982 Mar; 158(3):168-73. PubMed ID: 7071880 [TBL] [Abstract][Full Text] [Related]
38. Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy. Li SJ; Wehrle JP; Rajan SS; Steen RG; Glickson JD; Hilton J Cancer Res; 1988 Sep; 48(17):4736-42. PubMed ID: 3409214 [TBL] [Abstract][Full Text] [Related]
39. Correlations between 31P NMR spectroscopy and 15O perfusion measurements in the RIF-1 murine tumor in vivo. Evelhoch JL; Sapareto SA; Nussbaum GH; Ackerman JJ Radiat Res; 1986 Apr; 106(1):122-31. PubMed ID: 3961103 [TBL] [Abstract][Full Text] [Related]
40. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply. Lyng H; Olsen DR; Southon TE; Rofstad EK Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]